秋田微(300939.SZ):公司產品出口至美國佔比較低,受影響較小
格隆匯5月14日丨秋田微(300939.SZ)公佈,公司長期專注於觸控顯示行業,爲國內外客戶提供定製化的液晶顯示及觸控產品。1、公司產品出口至美國佔比較低,受影響較小,目前公司生產經營情況一切正常;2、根據美國海關與邊境保護局(CBP)2025年04月11日發佈的關於互惠關稅豁免的更新指南,豁免範圍覆蓋液晶顯示器;3、中美雙方於2025年05月12日達成經貿協議,美方取消91%對華加徵關稅,調整後的關稅政策於2025年05月14日正式生效;4、公司將密切關注貿易政策、貿易環境的變化與發展,積極靈活調整市場策略和經營管理策略,同時加大業務佈局,增強公司抗風險能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.